As a pediatric nephrologist, I specialize in treating hypertension and chronic kidney disease (CKD) with a focus on cardiovascular risk factors. I believe that every patient is unique and requires an individualized approach, and every member of our team is dedicated to providing the best possible care.
In my practice, we use a team approach that includes an excellent group of nurses, dietitians, medical assistants, CKD nurse managers, social workers and pharmacists who have worked together for many years. We understand how important it is to get input from the family, and we emphasize family involvement in each child’s care.
We are one of very few practices in the U.S. that includes a team of both cardiologists and nephrologists taking care of patients with hypertension. Our chronic kidney disease program is one of the largest in the country providing complex care.
In addition to caring for patients, I’m involved in research. One of my major goals is to reduce the frequency of cardiovascular risk in children with CKD. Cardiovascular disease is one of their major complications, and many children with advanced CKD develop hypertension, high cholesterol levels, heart abnormalities and stiff arteries.
Since 2003, I have been involved in the Chronic Kidney Disease in Children (CKiD) study, which is a large, multicenter study of children with CKD. More than 1,000 children have been participating in this study from more than 50 centers in the U.S. and Canada. I lead the cardiovascular arm of this large study, with the main goals of identifying cardiovascular risk factors and finding the best approach to prevent the development of cardiovascular disease and reduce its frequency.
I’m honored to have received numerous awards, including the Procter Scholar Award from the Cincinnati Children’s Research Foundation, the Pediatrician Scientist Award from the Children’s Health Research Center at the National Institutes of Health (NIH), and the Clinical Scientist Award from the National Kidney Foundation. I’ve also received multiple grants from the NIH, the American Heart Association and the National Kidney Foundation. I’ve been invited to speak about my research and the clinical aspects of hypertension at centers around the world. I have also been on the list of Cincinnati Magazine’s list of Best Doctors since 2007.
In my free time, I enjoy traveling, reading and spending time with my family.
MD: Gorky Medical Institute, Gorky, Russia, 1985.
Residency: Miami Children's Hospital, Miami, FL, 1997.
Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2000.
MS: Epidemiology and Biostatistics, University of Cincinnati, Cincinnati, OH, 2001.
Certifications: Educational Commission for Foreign Medical Graduates (ECFMG), 1995; Pediatrics, 1996; Pediatric Nephrology, 2001, 2008.
Chronic renal disease, dialysis, renal transplantation, hypertension
Cardiovascular complications of chronic renal disease, clinical trials in hypertension
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Interval healthcare provider contact and blood pressure control in children with chronic kidney disease and hypertension. Pediatric Nephrology. 2025; 40:2579-2587.
Hypertension, proteinuria, and RAAS inhibition use in children with systemic lupus erythematosus: Data from a multi-institutional pediatric learning health system. Lupus. 2025; 34:832-843.
A Multi-Omics Approach to Defining the Target Organ Injury in Youth with Primary Hypertension. Journal of Molecular and Cellular Cardiology Plus. 2025; 12:100339.
Youth Blood Pressure and Target Organ Injury Markers: The SHIP AHOY Study. Hypertension. 2025; 82:992-1001.
Kidney consequences of obesity. Pediatric Nephrology. 2025; 40:1879-1893.
Investigation of a targeted panel of gut microbiome-derived toxins in children with chronic kidney disease. Pediatric Nephrology. 2025; 40:1759-1770.
Kidney Function Following COVID-19 in Children and Adolescents. JAMA Network Open. 2025; 8:e254129.
Systolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents. Hypertension. 2024; 81:2444-2453.
Clinical characteristics and favorable treatment responses of recurrent focal segmental glomerulosclerosis or steroid-resistant nephrotic syndrome in children after kidney transplantation. Pediatric Nephrology. 2024; 39:3317-3331.
Acylcarnitines and Cardiovascular Outcomes in the CKD in Children (CKiD) and Chronic Renal Insufficiency Cohort (CRIC) Studies. Journal of the American Society of Nephrology : JASN. 2024; 35:10.1681/asn.2024wrzm5r35.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey